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Abstract
Background: The LIM domain protein Fhl5 was previously found to interact with CREM, a DNA
binding transcriptional regulator necessary for spermiogenesis in mammals. Co-transfection
experiments using heterologous promoter constructs indicated a role for Fhl5 in transcriptional
up-regulation of CREM-dependent testicular genes. Male mice lacking Fhl5 were reported to be
fertile but displayed partially abnormal sperm maturation and morphology.
Methods: To identify Fhl5 testicular target genes we carried out two whole-genome expression
profiling experiments using high-density oligonucleotide microarrays and total testis samples from
Fhl5 wild-type versus homozygous mutant mice first in different and then in isogenic strain
backgrounds.
Results:  Weak signal differences were detected in non-isogenic samples but no statistically
significant expression changes were observed when isogenic Fhl5 mutant and wild-type samples
were compared.
Conclusion: The outcome of these experiments suggests that testicular expression profiling is
extremely sensitive to the genetic background and that Fhl5 is not essential for testicular gene
expression to a level detected by microarray-based measurements. This might be due to redundant
function of the related and similarly expressed protein Fhl4.
Background
Sexual reproduction of male mammals requires genes
involved in meiosis, sperm formation and maturation as
well as fertilization many of which are controlled by
developmental stage-specific transcription factors [1,2].
Induction of post-meiotic gene expression is in part
dependent upon the τ activator isoform of CREM (Cyclic
AMP-Responsive Element Modulator) essential for sper-
matogenesis (for reviews, see [3-5]). Using a yeast two-
hybrid assay CREM was shown to bind Fhl5 which is spe-
cifically expressed in meiotic spermatocytes and highly
induced in post-meiotic round spermatids. Fhl5 is a pro-
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tein containing four and a half LIM domains which are
protein-protein interaction motifs found in many factors
required for processes such as transcription, cell structure
and motility as well as signal transduction [6-9]. The pro-
tein was shown to mediate strong reporter gene expres-
sion in transfection assays using heterologous promoter
constructs in yeast and mammalian cells and its dynamic
pattern of nuclear and cytoplasmic localization during
early and late stages of spermiogenesis is mediated via
direct interaction with the Kif17b kinesin motor protein
[10-13]. Fhl5 is a member of a family of five related LIM
domain proteins one of which, Fhl4, is also transcribed in
testis showing peak induction in spermatids [11,14]. Fhl5
expression in pachytene spermatocytes and round sper-
matids was proposed to be dependent upon CREM not
only in rodents but also in human; weak transcription of
Fhl5 was found in three out of four infertile patients
whose testes contained meiotic germ cells normally
expressing the gene, suggesting a link between impaired
Fhl5 function and spermatogenic arrest in a subgroup of
individuals [15-18].
While CREM is essential for spermatogenesis, Fhl5 is not
because mutant male mice were found to be fertile. How-
ever, they displayed partially abnormal sperm maturation
and morphology which was suggested to be a conse-
quence of impaired CREM/Fhl5-dependent post-meiotic
gene expression [19]. Three testicular genes reported to be
directly controlled by CREM continued to be expressed
normally in the absence of Fhl5 but since numerous tes-
ticular transcripts were shown to depend upon CREM
many candidate genes remained to be investigated
[19,20].
To identify Fhl5 target genes, a whole-genome expression
profiling experiment using total testicular samples and
high-density oligonucleotide microarrays (GeneChips)
containing probes for all known mouse protein-coding
genes was carried out. We report that deletion of Fhl5 does
not have a measurable effect on testicular gene expression
at the level of sensitivity reached by microarray analysis
when wild-type and Fhl5 mutant mice are examined in an
isogenic background.
Methods
Mouse strains
The initial experiment was carried out with Fhl5-/- mice
from a mixed genetic background (C57BL/6 and 129/
SvPas) [19] as compared to wild-type mice described in
reference [14]. The second experiment was done with Fhl5
+/+ and -/-littermates from a back-crossed strain (129/
SvPas).
PCR validation
Genotyping was done using allele specific primers as in
reference [19].
Testicular sample preparation
Decapsulated total testis samples were prepared from
adult mice at the age of 9 weeks (C57BL/6 and 129/SvPas)
as well as 9 and 14 weeks (129/SvPas) using a protocol as
described [14].
Target synthesis, GeneChip hybridization and raw data 
production
Total RNA preparation, cRNA target synthesis and raw
data production using MG430 2.0 GeneChips (Affyme-
trix) was done as previously published [14,21]. Total RNA
and cRNA quality was controlled using RNA Nano 6000
Chips and the BioAnalyzer; a virtual gel was created using
a software option as recommended by the manufacturer
(Agilent).
Data processing and cluster analysis
Data analysis was essentially done as published using
tools implemented in AMEN [14,22]. The data were nor-
malized using the Robust Multi-array Average (RMA)
method. Briefly, in the first experiment 23222 probe sets
that yielded signals greater than 5.5 (median of normal-
ized log2 transformed expression signals) were selected.
Among 417 showing a fold-change across the samples ≥ 2
we identified 212 as significant with a LIMMA statistical
test (F-value adjusted with False Discovery Rate ≤ 0.01).
The genes were separated into two groups using k-means
clustering.
In the second experiment 23921 probe sets were selected
for which signal intensities >5.5 (median) were observed.
Among those 21 showed a fold-change ≥ 2 but none was
identified as reproducibly differentially expressed using
LIMMA (F-value adjusted with FDR ≤ 0.01).
MIAME compliance
Raw data CEL files are available for downloading via the
EBI's ArrayExpress public repository [23] under the acces-
sion numbers E-TABM-130 (wild-type total testis control
sample in the C57BL/6 and 129/SvPas background) [14]
and E-TABM-806.
Results
The phenotype of Fhl5 -/- in a homogenous genetic 
background is exacerbated
It was previously reported that deletion of Flh5 in a mixed
genetic background (C57BL/6 & 129/SvPas) did not
impair fertility but resulted in reduced sperm counts,
altered sperm motility and partially abnormal morphol-
ogy [19]. To exclude the possibility that the complex back-
ground might mask a role of Flh5 in spermatogenesis aReproductive Biology and Endocrinology 2009, 7:133 http://www.rbej.com/content/7/1/133
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back-cross experiment was carried out and the testicular
morphology of the resulting mice was investigated. The
gene deletion phenotype in a homogenous background
(129/SvPas) was more pronounced but the mice were still
fertile (P. Sassone-Corsi, unpublished observation). We
conclude that Flh5's role in sperm maturation and mor-
phology is partially sensitive to the genetic background it
is investigated in.
Experimental procedure and quality control
To identify Flh5 target genes we first obtained decapsu-
lated total testicular samples from mutant mice (C57BL/6
& 129/SvPas) whose genotype was verified by PCR and
Western blotting (not shown). For practical purposes and
cost-effectiveness cRNA targets were synthesized from the
mutant mice testes, hybridized to MG430 2.0 GeneChips
and compared to testicular and cell-type specific data
from B6129SF2/J wild-type mice already available in our
laboratory [14]. We detected weak differential expression
for a very small number of genes that appeared however
completely unrelated to post-meiotic male germline func-
tions and known CREM targets. Therefore we next sought
to exclude the possibility that differences in RNA concen-
tration were due to heterogeneous genetic backgrounds
between wild-type and mutant samples rather than the
deletion of Fhl5. The experiment was repeated using
Fhl5+/+ and -/- littermates from a homogeneous back-
crossed strain (129/SvPas). The total RNA and cRNA sam-
ples were homogenous and of good quality (Figure 1,
panel A) and the signal intensity distributions were in the
Signal distribution and global similarity of samples Figure 1
Signal distribution and global similarity of samples. Panel A gives RNA quality data shown as a virtual gel as indicated. A 
green bar is the internal standard. Molecular weight markers are shown (MW). The fragment size is given in bases. Panel B 
shows box plots of log 2-transformed signal intensities (y-axis) for the testicular samples as indicated (x-axis) before normaliza-
tion (wild-type samples from the B6129SF2/J background not shown [14]). Panel C summarizes the overall degree of expres-
sion data similarity using a color-coded distance matrix (white is identical, back is most dissimilar). A dendrogram (top and left) 
shows the pattern of sample clustering observed.Reproductive Biology and Endocrinology 2009, 7:133 http://www.rbej.com/content/7/1/133
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Figure 2 (see legend on next page)Reproductive Biology and Endocrinology 2009, 7:133 http://www.rbej.com/content/7/1/133
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normal range across the dataset (panel B). Overall signal
similarity was studied using a distance matrix in combina-
tion with a dendrogram. The samples from the mixed
background were set off but all other samples appeared to
be very similar overall and no clear separation of wild-
type versus mutant testis was detected (panel C).
Flh5 is not essential for testicular gene expression in adult 
mice
In the first experiment we compared two testicular sam-
ples from non-isogenic Fhl5 mutant and wild-type mice at
the age of 9-10 weeks and identified among 45101 probe
sets a set of 23222 cases displaying signals greater than
5.5, the median of the normalized log2 intensity values
which we considered the cut-off for reliably detectable
expression. We then employed the statistical LIMMA test
to select 212 probe sets showing a fold-change greater
than 2 (F-value adjusted with FDR ≤ 0.01). For further
interpretation these probe sets were grouped into two
clusters using a k-means algorithm that distinguished
transcripts for which signals were either stronger (149) or
weaker (63) in the mutant as compared to the wild-type
strain. No Gene Ontology terms [24] were found to be sig-
nificantly enriched among the two expression clusters and
most genes affected were not expressed in spermatids
where FHL5 exerts its function as an activator (Figure 2,
panel A and C). To examine if these differences were due
to distinct genetic backgrounds of wild-type and mutant
mice rather than deletion of FHL5 per se, total RNA was
prepared from back-crossed mice's total testis samples at
9-15 weeks of age. Strikingly, no differentially expressed
genes were detected and as a consequence none of the
genes first identified as up- or down-regulated showed any
change of transcription between wild-type and mutant
samples from animals that were litter mates (Figure 2,
panel A and B).
We next investigated the expression patterns of genes pre-
viously identified as being differentially expressed in testis
(DET) using enriched Sertoli cells, spermatogonia, sper-
matocytes and spermatids [14]. None of the genes falling
into four somatic, mitotic, meiotic, and post-meiotic
expression clusters (notably the post-meiotic one) dis-
played altered expression in the absence of FHL5 (Figure
3). Finally, we analysed the expression of genes found to
depend upon CREM within our dataset and again
detected no difference between wild-type and mutant
samples (Figure 4) [20].
Discussion
Fhl5 has initially been identified as a CREM-binding fac-
tor required for gene activation in the male germline. It
was our aim to verify the hypothesis that abnormal sperm
maturation and morphology observed in mutant mice
lacking Fhl5 was due to impaired CREM-dependent gene
expression. To this end we carried out two independent
profiling experiments using total testicular samples and
MG430 2.0 GeneChips covering all known protein-cod-
ing genes of the mouse genome.
The first experiment was based on total testicular samples
from adult nine week-old Fhl5-/- mice produced in a
mixed genetic background (C57BL/6 and 129/SvPas) [19]
that were compared to data previously obtained with
wild-type samples isolated at the same age but from
another strain (B6129SF2/J) [14]. We considered this
cost-effective and time-saving approach acceptable in
spite of the influence of genetic backgrounds on gene
expression which is especially pertinent in the case of
human samples [25] because Fhl5 was a potent activator
in transfection experiments [10,26]. However, among the
genes we found in our initial experiment using Fhl5+/+
and -/- samples from different backgrounds none played
a role in spermiogenesis, sperm maturation or fertility and
not a single one fell into the group of CREM target genes
previously identified by microarray analysis [20]. A
detailed second expression analysis of litter mates failed
to yield any differentially expressed genes in 12 samples
from adult mice including five wild-type and seven
mutant animals. It should be emphasized that these mice
stemmed from a back-crossed strain background that dis-
played a stronger phenotype than the Fhl5 deletion in the
initial mixed background (P. Sassone-Corsi, unpublished
observation).
Expression profiling of FHL5 mutant (-/-) versus wild-type (+/+) testes Figure 2 (see previous page)
Expression profiling of FHL5 mutant (-/-) versus wild-type (+/+) testes. Panel A shows a color-coded heatmap for 
two groups of genes (up and down-regulated) as indicated by red and blue vertical bars when C57BL/6 & 129/SvPas -/- and 
B6129SF2/J +/+ were compared. Panel B displays data for these groups obtained in a different sample set as shown. Panel C dis-
plays the data obtained with purified testicular cells. The strain background is given at the top for wild-type (+/+) and mutant (-
/-) samples. The age distribution of the mice is given. TT is total testis. Samples are in panel A column 1 (KO_09_01, 
KO_09_02), column 2 (WT_1 and WT_2), panel B column 1 (KO_10_106, KO_10_107, KO_11_91, KO_12_86, KO_12_87), 
column 2 (KO_16_52, KO_17_60), column 3 (WT_10_105, WT_10_108, WT_11_92) and column 4 (WT_17_61, 
WT_17_62). Panel C shows duplicate samples of Sertoli cells (SE), spermatogonia (SG), spermatocytes (SC), and spermatids 
(ST) purified from animals at the appropriate ages [14]. The color code for log2-transformed signals is indicated by a scale to 
the right of the heatmap ranging from the weakest signal 1 (dark blue) to the strongest signal 15 (dark red).Reproductive Biology and Endocrinology 2009, 7:133 http://www.rbej.com/content/7/1/133
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The pattern of genes Differentially Expressed in Testis (DET) in FHL5 wild-type versus mutant samples Figure 3
The pattern of genes Differentially Expressed in Testis (DET) in FHL5 wild-type versus mutant samples. The 
DET group was identified in [14]. A heat map is shown that displays the expression signals in testis in the presence and absence 
of FHL5 for genes showing peak expression in Sertoli cells (Somatic), spermatogonia (Mitotic), spermatocytes (Meiotic) and 
spermatids (Post-Meiotic). Samples and scale are as in Figure 2.Reproductive Biology and Endocrinology 2009, 7:133 http://www.rbej.com/content/7/1/133
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The pattern of CREM-dependent genes in FHL5 wild-type versus mutant samples Figure 4
The pattern of CREM-dependent genes in FHL5 wild-type versus mutant samples. A heat map summarizes expres-
sion signals in testis in the presence and absence of FHL5 for genes reported to be transcriptionally dependent upon CREM 
[20]. Samples and scale are as in Figure 2.Reproductive Biology and Endocrinology 2009, 7:133 http://www.rbej.com/content/7/1/133
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The most obvious explanation of these results is that the
loci identified in the first experiment showed distinct
expression patterns because we compared samples from
different genetic backgrounds while the second experi-
ment based on isogenic litter mates revealed that Fhl5 is
not essential for testicular gene expression at the level of
sensitivity achieved with microarrays and whole gonad
samples. This result is in keeping with a previous report
that the absence of Fhl5 has no effect on the expression of
known CREM targets such as TNP1, PRN1 or PRN2 as
assayed by PCR [19]. It also concurs with the fact that
point mutations in the human ortholog of Fhl5 occur
with the same frequency in fertile individuals and azoo- or
oligozoospermic patients which argues against an essen-
tial role for the protein in human spermatogenesis
[18,27]. It is possible that Fhl5's in vivo role as a transcrip-
tional regulator is too subtle to be detected by whole-
genome profiling using total testicular samples and that
highly enriched populations of round spermatids would
have to be used instead. We consider this unlikely, how-
ever, since Fhl5 was reported to be a strong activator and
approximately 60% of the adult testicular cell mass con-
sists of spermatids [10].
An alternative explanation is that a related factor to a large
degree compensates the deletion of Fhl5 such that tran-
scriptional effects are masked while sperm maturation
and morphology remain partially abnormal. One likely
candidate is the LIM-domain protein Fhl4 which was ini-
tially shown to be expressed in testis [11,28] and later
found to be absent in spermatogonia and highly induced
in spermatocytes and spermatids by microarray analysis
[14]. Fhl4 weakly activates a heterologous reporter con-
struct in yeast and mammalian cells but it cannot, as
opposed to Fhl5, bind to CREM in a yeast two-hybrid
assay [11]. However, this does not exclude the native Fhl4
protein from being able to partially take over roles of Fhl5
in the physiological context of adult testicular tissue, espe-
cially in the absence of functional Fhl5.
Conclusion
The corollary of our work is that deletion of Fhl5 does not
cause any significant changes in testicular expression at
the genome-wide level at a level detectable by high-den-
sity oligonucleotide microarray expression profiling when
compared to an isogenic wild-type sample. We speculate
that this is the case because Fhl5 is redundant with Fhl4, a
structurally related factor showing a similar testicular
expression pattern. If this idea were correct, mice lacking
Fhl4 should display a phenotype reminiscent of the one
reported for Fhl5 mutants while deletion of both genes
should disrupt spermatogenesis at the post-meiotic stage
because of impaired CREM-dependent gene expression.
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